(1)
Evaluating Fluoxetine’s Growth-Inhibitory Impact on Clinical Isolates of Enteric Bacteria: Harnessing Repurposing Potential. MIC 2023, 2 (2), 89-96. https://doi.org/10.55627/mic.002.02.0454.